What can we expect from liposomal drugs?
- PMID: 11398872
- DOI: 10.1023/a:1011128621302
What can we expect from liposomal drugs?
Comment on
-
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.Ann Oncol. 2001 Apr;12(4):457-62. doi: 10.1023/a:1011181016401. Ann Oncol. 2001. PMID: 11398876 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources